A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.

Hans C LeeJatin J ShahLei FengElisabet E ManasanchRebecca LuAshley MorpheyBrandon CrumptonKrina K PatelMichael L WangRaymond AlexanianSheeba K ThomasDonna M WeberRobert Z Orlowski

Published in: Blood cancer journal (2019)

Keyphrases

multiple myeloma
open label
high dose
low dose
placebo controlled
double blind
clinical trial
randomized controlled trial
acute lymphoblastic leukemia
diffuse large b cell lymphoma